We are live on ! Find out more
BSPM

Biostar Pharmaceuticals, Inc.
BSPM

Delisted

BSPM was delisted on the 18th of September, 2018.

Back to rankings

1 hedge funds and large institutions have $2K invested in Biostar Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
+$2K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$2K +$2K +6,016 New

BSPM Hedge Fund Activity: Q4 2018 in Review

1 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q4 2018, worth a combined $2K.

Buyers outnumbered sellers: 1 fund opened new BSPM positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Panagora Asset Management, opening a new position worth an estimated $2K.

  • 1 institutional investor held Biostar Pharmaceuticals, Inc. (BSPM) as of Q4 2018, up from 0 in Q3 2018.
  • Funds reported $2K of Biostar Pharmaceuticals, Inc. stock for Q4 2018.
  • 1 fund opened new Biostar Pharmaceuticals, Inc. positions in Q4 2018 and 0 closed out, a net change of +1 holder.
  • The largest Biostar Pharmaceuticals, Inc. buyer in Q4 2018 was Panagora Asset Management, an estimated $2K added.

Based on aggregated 13F filings for Q4 2018.